Hands-on biotech training delivers credentials, research projects, and real lab access for San Antonio students—fueling ...

China quietly became biotech’s back-office, from molecule synthesis and clinical trials to novel drug licensing. Now the ...

IBB ETF analysis: hold rating as biotech consolidates near highs. Fair 19x P/E, low EPS growth and weak seasonality shape ...

A research team led by the University of Oxford's Department of Engineering Science has shown it is possible to engineer a ...

Learn how LABD delivers -3x daily biotech exposure, why it’s down 99.98% since inception, and when it fits short-term trades.

A successful Phase 3 trial and a public offeringof stock boosted prospects for this company to receive approval for an exciting new treatment.

Biotechnology is the exploitation of biological processes for the development of technologies and products for a specific use. GlobalData’s Strategic Intelligence report on biotech details how recent ...

Now, it’s worth noting Stock Advisor’s total average return is 949 % — a market-crushing outperformance compared to 195% for ...

Explore India's potential in futuristic marine and space biotechnology to enhance biomanufacturing and strengthen its ...

Moyom Biotechnology recently announced a strategic partnership with WPP Group, one of the world's leading global ...

A surge in deals and financings had the industry abuzz heading into this year’s J.P. Morgan Healthcare Conference. But some ...

Explore evolving career pathways in biotechnology, emphasizing innovation, sustainability, and interdisciplinary skills from ...